Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 17Colorectal Neoplasms 3Postoperative Complications 2Anastomotic Leak 2Transfusion Reaction 1Recurrence 1Rectal Cancer Stage T1-T2 1Pathologic Complete Response 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Colitis, Ischemic 1Coitus 1

Interventions

Oxaliplatin 3Fluorouracil 3Radiotherapy 2Immune Checkpoint Inhibitors 2Endoscopy 2Drug Therapy 2Chemoradiotherapy 2toripalimab 1tislelizumab 1pembrolizumab 1X-Rays 1Tretinoin 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proctectomy 1Positron Emission Tomography Computed Tomography 1Neoadjuvant Therapy 1Magnetic Resonance Imaging 1Leucovorin 1Immunotherapy 1Immunohistochemistry 1Esophagectomy 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Docetaxel 1Diffusion Magnetic Resonance Imaging 1Cisplatin 1Capecitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Proctectomy × Gastrointestinal × Clear all
NCT03601689 2018-07-26

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Moroccan Society of Surgery

Completed
84 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡